Indian Journal of Urology Users online:837  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2021  |  Volume : 37  |  Issue : 1  |  Page : 54-58

Tubeless mini-percutaneous nephrolithotomy for renal stones larger than 20 mm

1 Department of Urology, Vayodha Hospital, Kathmandu, Nepal
2 Department of Urology, University Hospital Birmingham NHS Foundation Trust, Birmingham, England, United Kingdom
3 Department of Surgery, Urology Unit, AL-Amiri Hospital, Kuwait City, Kuwait; Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
4 Department of Surgery, Urology Unit, AL-Amiri Hospital, Kuwait City, Kuwait

Correspondence Address:
Ahmed R EL-Nahas
Department of Surgery, Urology Unit, AL-Amiri Hospital, Kuwait City; Urology and Nephrology Center, Mansoura University, Mansoura

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/iju.IJU_271_20

Rights and Permissions

Introduction: The aim of this study is to evaluate the outcomes of tubeless mini- percutaneous nephrolithotomy (PCNL) for the treatment of large (>20 mm) renal stones. Patients and Methods: This study included consecutive patients who underwent single-session tubeless mini-PCNL (tract size 16–20 F) for large (>20 mm) renal stones. Stone-free status meant complete clearance or residual fragments <4 mm. Complications were recorded and classified according to modified Clavien-Dindo classifications. Risk variables for significant residuals were determined with univariate (Chi-square and t-test) and multivariate logistic regression analyses. Results: Between July 2015 and November 2018, 225 patients were included. The mean age was 42.9 years; the mean stone size was 30.2 ± 9.6 mm and 75% of patients were males. A single renal stone was present in 54 patients (24%), multiple stones in 108 (48%), and staghorn stones in 63 (28%). The stone-free rate was 87.6%. The complication rate was 8.4% (Grade I–II in 7.5%, III in 0.9%). Three patients (1.3%) required blood transfusion. Independent risk factor for significant residual fragments was the presence of stones in multiple sites inside the pelvicalyceal system (relative risk: 13.44, 95% confidence interval: 1.78–101.43, P = 0.012). Conclusions: Mini-PCNL is an effective and safe treatment option for patients with large renal stones (>20 mm). Stones located in multiple sites is the only predictor of significant residual stones.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded148    
    Comments [Add]    

Recommend this journal